Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal drug therapy

M I Evans1, P G Pryde, A Reichler

  • 1Department of Obstetrics and Gynecology, Hutzel Hospital, Detroit, Michigan 48201.

The Western Journal of Medicine
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2014
Same author

Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

Chlamydia trachomatis: a practical obstetric/gynecologic management approach.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2010
Same author

Peeling back the onion on ultrasound abnormalities.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2009
Same author

Doppler and gray-scale sonographic classification of adnexal torsion.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2009
Same author

Second-trimester sonographic soft markers: what can we learn from the experience of first-trimester nuchal translucency screening?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2008
Same journal

Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
Same journal

[Not Available].

The Western journal of medicine·2008
See all related articles

Fetal drug therapy offers treatments for congenital adrenal hyperplasia, metabolic disorders, and cardiac issues. It also aids in preventing neural tube defects and inducing fetal lung maturity, with evolving administration routes.

Area of Science:

  • Perinatology
  • Maternal-Fetal Medicine
  • Pharmacology

Background:

  • Fetal drug therapy addresses diverse conditions, including congenital adrenal hyperplasia and metabolic disorders.
  • Cardiac arrhythmia correction and neural tube defect risk reduction are established applications.
  • Induction of fetal lung maturity is another key area of fetal pharmacotherapy.

Purpose of the Study:

  • To review the current landscape of fetal drug therapy.
  • To highlight key applications and evolving administration methods.
  • To underscore the advancements in treating fetal conditions.

Main Methods:

  • Review of existing literature on fetal drug therapies.
  • Analysis of therapeutic areas and outcomes.

Related Experiment Videos

  • Examination of drug administration routes in utero.

    • Main Results:

    • Successful interventions include preventing virilization in 21-hydroxylase deficiency and managing metabolic disorders.
    • Folic acid use reduces neural tube defect risks, while corticosteroids induce fetal lung maturity.
    • Maternal-placental drug administration remains common, with increasing direct fetal administration.

    Conclusions:

    • Fetal drug therapy is a rapidly advancing field with significant impact on neonatal outcomes.
    • Therapeutic options continue to expand, offering new hope for various fetal conditions.
    • Innovations in drug delivery are enhancing treatment efficacy and safety.